Results 231 to 240 of about 4,150,951 (316)

Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT) is the second‐most common inherited bleeding disorder worldwide, afflicting one in 4000–5000 people, and is the most morbid inherited bleeding disorder of women. HHT causes recurrent severe epistaxis, chronic gastrointestinal bleeding, heavy menstrual bleeding, and arteriovenous malformations in the ...
Hanny Al‐Samkari   +5 more
wiley   +1 more source

How to Define and Manage Low-Risk Drug Allergy Labels. [PDF]

open access: yesJ Allergy Clin Immunol Pract
Copaescu AM   +3 more
europepmc   +1 more source

Drug Allergy in children: focus on beta-lactams and NSAIDs. [PDF]

open access: yesActa Biomed, 2020
Cravidi C   +12 more
europepmc   +1 more source

International Consensus on drug allergy

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2014
P. Demoly   +12 more
semanticscholar   +1 more source

Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP

open access: yesAmerican Journal of Hematology, EarlyView.
Anti‐ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post‐TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen. ABSTRACT Current triplet regimens associating therapeutic plasma exchange (TPE), immunosuppression with corticosteroids and rituximab, and caplacizumab have ...
Marie Robert   +29 more
wiley   +1 more source

Psychological profiles of patients with suspected drug allergy. [PDF]

open access: yesAsia Pac Allergy, 2020
Dias de Castro E   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy